N
Nicola Pusterla
Researcher at University of California, Davis
Publications - 342
Citations - 7015
Nicola Pusterla is an academic researcher from University of California, Davis. The author has contributed to research in topics: Lawsonia intracellularis & Ehrlichia. The author has an hindex of 41, co-authored 313 publications receiving 6056 citations. Previous affiliations of Nicola Pusterla include University of Kentucky & University of Southern California.
Papers
More filters
Journal ArticleDOI
Oleander toxicosis in equids: 30 cases (1995-2010)
Anna C. Renier,Philip H. Kass,K. Gary Magdesian,John E Madigan,Monica R Aleman,Nicola Pusterla +5 more
TL;DR: Oleander intoxication should be a differential diagnosis for equids with colic in geographic areas where oleander is found, especially when azotemia or cardiac arrhythmias are detected concurrently.
Journal Article
Clinical examination upon suspicion of bovine spongiform encephalopathy (BSE)
TL;DR: The most important clinical signs of BSE are hypersensitivity to manipulations of the head and neck and disturbances in behaviour and locomotion as mentioned in this paper, which is the most common clinical signs for BSE.
Journal ArticleDOI
Serological, Hematologic, and PCR Studies of Cattle in an Area of Switzerland in Which Tick-Borne Fever (Caused by Ehrlichia phagocytophila) Is Endemic
TL;DR: The incidence of clinical signs of ehrlichiosis was increased in cattle grazing on the pastures of endemicity for the first time and in serum titers of antibody to E. phagocytophila was similar to that of seroprevalence.
Journal ArticleDOI
Multicentric T-cell lymphosarcoma in an alpaca
TL;DR: A two-year-old female alpaca with multicentric lymphosarcoma presented because of progressive weakness and recumbency and Immunophenotyping using cross reactive T- and B-cell antibodies characterized the tumour as a T-cell lymphosArcoma.
Journal ArticleDOI
Use of viral loads in blood and nasopharyngeal secretions for the diagnosis of EHV-1 infection in field cases.
TL;DR: The increasing application of sensitive molecular diagnostic techniques for the detection of pathogens in practice settings has presented new dilemmas with regard to how test results are interpreted and used by both equine practitioners and regulatory veterinarians.